BTIG cut its price target on Buy-rated AtriCure (NASDAQ: ATRC) from $34 down to $19 after the company reported Q2 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Form 10-Q AtriCure, Inc. For: Jun 30August 5, 2016 9:02 AM Needham & Company Cuts Price Target on AtriCure (ATRC) to $20; Reiterates Buy August 5, 2016 8:34 AM AtriCure (ATRC) Guidance Reset Should Be Positive Clearing Event - Piper JaffrayAugust 5, 2016 8:27 AM AtriCure (ATRC) Tops Q2 EPS by 4cAugust 4, 2016 5:16 PM